Andrew B. Wilks, MD, MS

Andrew B. Wilks, MD, MS, is a board-certified hematologist at Boston Medical Center (BMC) and an Assistant Professor of Medicine in the Section of Hematology & Medical Oncology at the Boston University Chobanian & Avedisian School of Medicine.

Dr. Wilks joined BMC in September 2023. Since joining, he has established a clinical focus on sickle cell disease (SCD) and gene therapy. His research has focused on biomarkers for SCD and expanding access for gene therapy, especially in HbSC and non-HbSS disease.

Dr. Wilks is a graduate of Tufts University School of Medicine where, in addition to his medical training, he received a master’s degree in biomedical sciences with a focus on cancer vaccines. He completed his residency training in internal medicine at the University of Vermont. During hematology/oncology fellowship at the University of Massachusetts Chan Medical School, Dr. Wilks focused on stem cell transplantation, which makes him a valuable asset to the gene therapy program at BMC.